142 related articles for article (PubMed ID: 9610924)
21. Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions.
Lin HQ; McGregor IS; Atrens DM; Christie MJ; Jackson DM
Pharmacol Biochem Behav; 1994 Feb; 47(2):369-74. PubMed ID: 7908448
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the role of 5-HT(2) receptor antagonism during subchronic antipsychotic drug administration in rats.
Kruzich PJ; See RE
Brain Res; 2000 Sep; 875(1-2):35-43. PubMed ID: 10967296
[TBL] [Abstract][Full Text] [Related]
23. Effects of intraaccumbens injections of dopamine agonists and antagonists on sucrose and sucrose-ethanol reinforced responding.
Hodge CW; Samson HH; Tolliver GA; Haraguchi M
Pharmacol Biochem Behav; 1994 May; 48(1):141-50. PubMed ID: 7913224
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity.
van den Boss R; Cools AR; Ogren SO
Psychopharmacology (Berl); 1988; 95(4):447-51. PubMed ID: 2975012
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
Smith JK; Neill JC; Costall B
Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
[TBL] [Abstract][Full Text] [Related]
26. Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward.
Frank RA; Tsibulsky V; Grocki S; Dashevsky B; Kehne JH; Schmidt CJ; Sorensen SM
Pharmacol Biochem Behav; 1995 Dec; 52(4):799-804. PubMed ID: 8587922
[TBL] [Abstract][Full Text] [Related]
27. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.
Sun W; Ginovart N; Ko F; Seeman P; Kapur S
Mol Pharmacol; 2003 Feb; 63(2):456-62. PubMed ID: 12527818
[TBL] [Abstract][Full Text] [Related]
28. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
Schotte A; de Bruyckere K; Janssen PF; Leysen JE
Brain Res; 1989 Oct; 500(1-2):295-301. PubMed ID: 2481562
[TBL] [Abstract][Full Text] [Related]
29. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex.
Pehek EA; Bi Y
Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):671-82. PubMed ID: 9194148
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
31. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
32. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
Barrett AC; Miller JR; Dohrmann JM; Caine SB
Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
[TBL] [Abstract][Full Text] [Related]
33. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Ginovart N; Farde L; Halldin C; Swahn CG
Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain.
Mendlin A; MartÃn FJ; Jacobs BL
Neuroscience; 1999; 93(3):897-905. PubMed ID: 10473255
[TBL] [Abstract][Full Text] [Related]
35. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
36. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
38. Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens.
Samson HH; Hodge CW; Tolliver GA; Haraguchi M
Brain Res Bull; 1993; 30(1-2):133-41. PubMed ID: 8093596
[TBL] [Abstract][Full Text] [Related]
39. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
Ohno Y; Ishibashi T; Okada K; Ishida K; Nakamura M
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1091-101. PubMed ID: 8584685
[TBL] [Abstract][Full Text] [Related]
40. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
Wadenberg ML
J Neural Transm Gen Sect; 1992; 89(1-2):49-59. PubMed ID: 1418867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
